Ewing's Sarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma
Conditions:   Metastatic Ewing Sarcoma;   Recurrent Ewing Sarcoma Interventions:   Procedure: Fine-Needle Aspiration;   Drug: Irinotecan;   Drug: Irinotecan Hydrochloride;   Drug: Lurbinectedin Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2021 Category: Research Source Type: clinical trials